04/08/2021

BDA helps showcase Bermuda’s Class of 2020

“As this report highlights, recent market conditions created compelling opportunities and Bermuda has once again been the jurisdiction of choice for new entrants and a surge of capital to established players.

04/08/2021

Record Q1 for TISE listings

It took the total number of listed securities on TISE up by more than 2.3% from the end of December 2020 to 3,235 at 31 March 2021.

04/06/2021

Highvern Establishes London Office

Moving forward, the London office will be able to service clients not only from Jersey but will also be able to respond to a growing demand to service clients with UK based private wealth and corporate structuring requirements.

03/30/2021

Apex enhances Loan Agency offering

Apex’s Capital Markets business supports clients planning and executing a broad cross-section of capital markets transactions to facilitate growth, respond to regulatory change, or manage risk.

03/29/2021

Islands lagging in the gender pay gap race

Guernsey and Jersey are falling behind on gender equality with one of the highest pay gaps internationally – but getting back on track will deliver huge benefits.

03/26/2021

Resolute Capital Partners Selects JTC

When Resolute Capital decided to expand globally and researched available fund administrator options, they awarded JTC the opportunity to administer their international feeder funds in Guernsey, a well-established fund domicile and a leading offshore fina

03/25/2021

Vision 2050: Time to Transform

Only collaboration at unprecedented levels will create the impact and speed needed to achieve all people living well within planetary boundaries by 2050.

03/25/2021

Obsidian Fund Services launches in Guernsey

Jody commented:"After 20 years in the industry I took a frank look around and was not happy with the commitment to service and quality generally across the sector.

03/24/2021

A Review of the 2020 IPO Capital Market

Hong Kong has now become the world’s second largest biotech fundraising hub, ushering in 47 healthcare and biotech listings to the Stock Exchange Main Board since the launch of the new listing regime.